scholarly journals Continuous Intravenous Infusion of Oxycodone for Dyspnea from End Stage-heart Failure due to Dilated Cardiomyopathy

2016 ◽  
Vol 11 (2) ◽  
pp. 529-533 ◽  
Author(s):  
Koji Ishii ◽  
Kumi Matsuo ◽  
Maki Ohno ◽  
Shigenori Muto ◽  
Satoru Morishita ◽  
...  
Keyword(s):  
Heart Failure ◽  
Dilated Cardiomyopathy ◽  
Intravenous Infusion ◽  
Continuous Intravenous Infusion ◽  
End Stage Heart Failure ◽  
End Stage

Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: Implications for dilated cardiomyopathy

2009 ◽  
Vol 131 (2) ◽  
pp. 246-256 ◽  
Author(s):  
Petros Athanassopoulos ◽  
Aggie H.M.M. Balk ◽  
Leonard M.B. Vaessen ◽  
Kadir Caliskan ◽  
Johanna J.M. Takkenberg ◽  
...  
Keyword(s):  
Heart Failure ◽  
Dendritic Cell ◽  
Dilated Cardiomyopathy ◽  
Phenotypic Characteristics ◽  
End Stage Heart Failure ◽  
End Stage ◽  
Blood Dendritic Cell

Early Acute Graft Rejection in a Heart Transplanted Child with Dilated Cardiomyopathy

2020 ◽  
Vol 6 (2) ◽  
pp. 43-47
Author(s):  
Iolanda Muntean ◽  
Asmaa Carla Barmou ◽  
Anca Ileana Sin ◽  
Horatiu Suciu ◽  
Rodica Togănel
Keyword(s):  
Heart Failure ◽  
Heart Transplantation ◽  
Dilated Cardiomyopathy ◽  
Endomyocardial Biopsy ◽  
Allograft Rejection ◽  
Neonatal Period ◽  
Common Type ◽  
Acute Graft Rejection ◽  
End Stage Heart Failure ◽  
End Stage

AbstractDilated cardiomyopathy (DCM) is the most common type of cardiomyopathy in children. Heart transplantation is considered standard therapy in dilated cardiomyopathy with end-stage heart failure. We present a case of a 15-year-old patient diagnosed with DCM in the neonatal period, who underwent heart transplantation for end-stage heart failure. Despite the use of induction therapy, the endomyocardial biopsy performed at two weeks post-transplant revealed mixed moderate cellular (2R) and humoral (pAMR2) allograft rejection. Aggressive rejection treatment was initiated with good outcome. Besides endomyocardial biopsy, advanced echocardiography can also be a valuable noninvasive tool for rejection assessment.

Challenges of Palliative Treatment for End-Stage Heart Failure “From a Report of Severe Heart Failure Due to Dilated Cardiomyopathy”

2011 ◽  
Vol 17 (9) ◽  
pp. S177
Author(s):  
Shogo Oishi ◽  
Takayoshi Toba ◽  
Naoki Miyoshi ◽  
Tomofumi Takaya ◽  
Yasue Tsukishiro ◽  
...  
Keyword(s):  
Heart Failure ◽  
Dilated Cardiomyopathy ◽  
Palliative Treatment ◽  
Severe Heart Failure ◽  
End Stage Heart Failure ◽  
End Stage

scholarly journals Identification of micro‐ RNA networks in end‐stage heart failure because of dilated cardiomyopathy

2013 ◽  
Vol 17 (9) ◽  
pp. 1173-1187 ◽  
Author(s):  
Xiaoming Zhu ◽  
Hongjiang Wang ◽  
Fan Liu ◽  
Li Chen ◽  
Weijia Luo ◽  
...  
Keyword(s):  
Heart Failure ◽  
Dilated Cardiomyopathy ◽  
Micro Rna ◽  
End Stage Heart Failure ◽  
End Stage

An embolic event contributes to death in 2/3 of patients with idiopathic dilated cardiomyopathy in end stage heart failure

2003 ◽  
Vol 9 (5) ◽  
pp. S98
Author(s):  
Antonio C.P. Barretto ◽  
Mucio T. Oliveira ◽  
Robinson T. Munhoz ◽  
Airton R. Scipioni ◽  
Maria L. Higuchi ◽  
...  
Keyword(s):  
Heart Failure ◽  
Dilated Cardiomyopathy ◽  
Idiopathic Dilated Cardiomyopathy ◽  
Embolic Event ◽  
End Stage Heart Failure ◽  
End Stage

scholarly journals 1108-112 An embolic event to death in more than 50 percent of patients with idiopathic dilated cardiomyopathy in end-stage heart failure

2004 ◽  
Vol 43 (5) ◽  
pp. A197-A198
Author(s):  
Antonio C Barretto ◽  
Mucio T Oliveira ◽  
Mucio T Oliveira ◽  
Robinson T Munhoz ◽  
Airton R Scipioni ◽  
...  
Keyword(s):  
Heart Failure ◽  
Dilated Cardiomyopathy ◽  
Idiopathic Dilated Cardiomyopathy ◽  
Embolic Event ◽  
End Stage Heart Failure ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document